In this 46:30 audio, Danny Cohen and myself discuss why we believe $GLYC will see successful data-read outs in all studies of Uproleselan (GMI-1271). In a general sense, it makes perfect sense to be short here and predict failure. We…
Summary Glycomimetics’ Uproleselan is expected to read out data in relapsed/refractory and elderly newly diagnosed Acute Myeloid Leukemia (AML) after 6 years in pivotal studies. AML is a disease with a poor prognosis, especially for elderly patients, and there is…
I’ll get to the point. This company is a platform story, not just AML. Additionally, if both NCI and Company sponsored AML trials prove-out, the peak sales are close to $1B, not the $300M most wrongly calculate. why? Uproleselan is…
[embeddoc url=”https://stockmatusow.com/wp-content/uploads/2017/12/DeAngelo-GMI-1271-201-ASH-2017-Abstract-894.pdf” viewer=”google”]
New Video Here For Premium Subscribers Onlyeo Here For Premium Subscribers Only, New Video Here For Premium Subscribers Only, New Video Here For Premium Subscribers Only, New Video Here For Premium Subscribers Only, New Video Here For Premium Subscribers Only…
Video – Biotech Catalyst Chart Review Video – Biotech Catalyst Chart Review Video – Biotech Catalyst Chart Review Video – Biotech Catalyst Chart Review Video – Biotech Catalyst Chart Review Video – Biotech Catalyst Chart Review . I listed the title a few times so…
My Trading Gains And Losses For The Year To Date – Video Documentation below. Exact trades will take a long time to compile, When I get the time, I will try to get that info as well; Scott
Video: Identiv Trading History Documented. So you know I did not pump and dump anyone. Gains/Losses coming up later. Scott
I am currently live for a free live audio show today. Market week wrap, questions, whatever u want to talk about, but keep it civil. Personal insults or the like will not be tolerated. Link below: http://stockmatusow.com/stockchat Be sure…
